AP3151A - Stable ready to use injectable paracetamol formulation - Google Patents
Stable ready to use injectable paracetamol formulationInfo
- Publication number
- AP3151A AP3151A AP2012006597A AP2012006597A AP3151A AP 3151 A AP3151 A AP 3151A AP 2012006597 A AP2012006597 A AP 2012006597A AP 2012006597 A AP2012006597 A AP 2012006597A AP 3151 A AP3151 A AP 3151A
- Authority
- AP
- ARIPO
- Prior art keywords
- use injectable
- stable ready
- paracetamol formulation
- injectable paracetamol
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10005258A EP2389923B1 (fr) | 2010-05-19 | 2010-05-19 | Formule de paracétamol injectable, stable et prête à utiliser |
PCT/EP2011/002482 WO2011144335A1 (fr) | 2010-05-19 | 2011-05-18 | Préparation de paracétamol injectable stable, prête à l'emploi |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2012006597A0 AP2012006597A0 (en) | 2012-12-31 |
AP3151A true AP3151A (en) | 2015-03-31 |
Family
ID=42338244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2012006597A AP3151A (en) | 2010-05-19 | 2011-05-18 | Stable ready to use injectable paracetamol formulation |
Country Status (22)
Country | Link |
---|---|
US (1) | US8877817B2 (fr) |
EP (1) | EP2389923B1 (fr) |
CN (1) | CN102985069B (fr) |
AP (1) | AP3151A (fr) |
BR (1) | BR112012029212A2 (fr) |
CA (1) | CA2799666C (fr) |
CY (1) | CY1113999T1 (fr) |
DK (1) | DK2389923T3 (fr) |
ES (1) | ES2403121T3 (fr) |
HK (1) | HK1182315A1 (fr) |
HR (1) | HRP20130184T1 (fr) |
MA (1) | MA34314B1 (fr) |
MY (1) | MY160458A (fr) |
PL (1) | PL2389923T3 (fr) |
PT (1) | PT2389923E (fr) |
RU (1) | RU2519764C1 (fr) |
SI (1) | SI2389923T1 (fr) |
SM (1) | SMT201300038B (fr) |
TN (1) | TN2012000516A1 (fr) |
UA (1) | UA104381C2 (fr) |
WO (1) | WO2011144335A1 (fr) |
ZA (1) | ZA201208605B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA201300398B (en) * | 2012-11-27 | 2013-09-25 | Genfarma Laboratories S L | Injectable liquid formulation of the combination of tramadol and paracetamol |
WO2016008546A1 (fr) * | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Formulation aqueuse comprenant du paracétamol et de l'ibuprofène |
CN105797166A (zh) * | 2016-03-30 | 2016-07-27 | 吉林长白山药业集团股份有限公司 | 用羟丙基环糊精包合对乙酰氨基酚制成液体制剂的方法 |
WO2018192664A1 (fr) | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | Procédé de préparation d'une composition à faible teneur en oxygène dissous, comprenant de l'acétaminophène, et éventuellement un ou plusieurs ains, et une composition obtenue à partir de celui-ci |
WO2019180072A1 (fr) | 2018-03-22 | 2019-09-26 | Bayer Pharma Aktiengesellschaft | Composition pharmaceutique parentérale consistant en du bialanate de néladénoson |
WO2021222835A1 (fr) * | 2020-04-30 | 2021-11-04 | Purser Danny C | Compositions et méthodes comprenant du glutathion réduit stable |
GR1010637B (el) * | 2023-01-13 | 2024-02-15 | Ιουλια Κλεωνος Τσετη | Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH648371A5 (de) | 1982-01-29 | 1985-03-15 | Fischer Ag Georg | Anschlusseinrichtung fuer armaturen. |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
FR2751875B1 (fr) | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
JP2001233787A (ja) * | 2000-02-04 | 2001-08-28 | Patents Exploitation Co Bv | 小・中サイズのペプチド含有薬学的組成物 |
US20040045546A1 (en) * | 2002-09-05 | 2004-03-11 | Peirce Management, Llc | Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use |
FR2851164B1 (fr) * | 2003-02-14 | 2005-04-22 | Xuan Tho Nguyen | Formulation liquide injectable de paracetamol |
JP5909750B2 (ja) * | 2007-11-13 | 2016-04-27 | マリンクロット アイピー | 低用量静脈内アセトアミノフェン |
WO2009098716A2 (fr) * | 2008-01-17 | 2009-08-13 | Aptuit Laurus Private Limited | Compositions pharmaceutiques aqueuses stables |
US20090246276A1 (en) * | 2008-01-28 | 2009-10-01 | Graham Jackson | Pharmaceutical Compositions |
NZ596979A (en) * | 2008-02-29 | 2012-06-29 | Meiji Co Ltd | Anti-allergic agent comprising a fermentation product of a propionic acid bacterium |
-
2010
- 2010-05-19 DK DK10005258.8T patent/DK2389923T3/da active
- 2010-05-19 PT PT100052588T patent/PT2389923E/pt unknown
- 2010-05-19 EP EP10005258A patent/EP2389923B1/fr active Active
- 2010-05-19 ES ES10005258T patent/ES2403121T3/es active Active
- 2010-05-19 PL PL10005258T patent/PL2389923T3/pl unknown
- 2010-05-19 SI SI201030168T patent/SI2389923T1/sl unknown
-
2011
- 2011-05-18 AP AP2012006597A patent/AP3151A/xx active
- 2011-05-18 MY MYPI2012004801A patent/MY160458A/en unknown
- 2011-05-18 UA UAA201214331A patent/UA104381C2/uk unknown
- 2011-05-18 CA CA2799666A patent/CA2799666C/fr not_active Expired - Fee Related
- 2011-05-18 MA MA35461A patent/MA34314B1/fr unknown
- 2011-05-18 WO PCT/EP2011/002482 patent/WO2011144335A1/fr active Application Filing
- 2011-05-18 US US13/695,785 patent/US8877817B2/en active Active
- 2011-05-18 BR BR112012029212-9A patent/BR112012029212A2/pt not_active Application Discontinuation
- 2011-05-18 CN CN201180024241.4A patent/CN102985069B/zh not_active Expired - Fee Related
- 2011-05-18 RU RU2012151433/15A patent/RU2519764C1/ru active
-
2012
- 2012-10-29 TN TNP2012000516A patent/TN2012000516A1/en unknown
- 2012-11-15 ZA ZA2012/08605A patent/ZA201208605B/en unknown
-
2013
- 2013-03-04 HR HRP20130184AT patent/HRP20130184T1/hr unknown
- 2013-03-22 CY CY20131100241T patent/CY1113999T1/el unknown
- 2013-04-03 SM SM201300038T patent/SMT201300038B/xx unknown
- 2013-08-16 HK HK13109609.9A patent/HK1182315A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2389923B1 (fr) | 2013-01-30 |
CA2799666C (fr) | 2016-02-16 |
WO2011144335A8 (fr) | 2012-12-06 |
DK2389923T3 (da) | 2013-03-18 |
PL2389923T3 (pl) | 2013-06-28 |
HRP20130184T1 (hr) | 2013-05-31 |
SI2389923T1 (sl) | 2013-06-28 |
HK1182315A1 (en) | 2013-11-29 |
WO2011144335A1 (fr) | 2011-11-24 |
CA2799666A1 (fr) | 2011-11-24 |
BR112012029212A2 (pt) | 2020-09-29 |
ES2403121T3 (es) | 2013-05-14 |
CY1113999T1 (el) | 2016-07-27 |
US8877817B2 (en) | 2014-11-04 |
AP2012006597A0 (en) | 2012-12-31 |
CN102985069B (zh) | 2014-11-26 |
SMT201300038B (it) | 2013-07-09 |
EP2389923A1 (fr) | 2011-11-30 |
ZA201208605B (en) | 2013-09-25 |
PT2389923E (pt) | 2013-03-28 |
TN2012000516A1 (en) | 2014-04-01 |
MA34314B1 (fr) | 2013-06-01 |
RU2519764C1 (ru) | 2014-06-20 |
MY160458A (en) | 2017-03-15 |
CN102985069A (zh) | 2013-03-20 |
US20130210922A1 (en) | 2013-08-15 |
UA104381C2 (uk) | 2014-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2387989T3 (da) | Langtidsvirkende formuleringer med insuliner | |
PL2616064T3 (pl) | Gotowe do zastosowania formulacje ketorolaku | |
GB201010193D0 (en) | Medicinal use | |
EP2685965A4 (fr) | Formulation combinée ayant une stabilité améliorée | |
DK2525798T3 (da) | Anæstetisk formulering | |
ZA201208726B (en) | High-temperature stable oxygen-carrier-containing pharmaceutical composition | |
IL221857A (en) | Liquid formulations are stabilized | |
HK1182315A1 (en) | Stable ready to use injectable paracetamol formulation | |
EP2599484A4 (fr) | Préparation pharmaceutique injectable de melphalane | |
HK1205877A1 (en) | Injectable ibuprofen formulation | |
GB201021267D0 (en) | Novel pharmaceutical formulation | |
EP2702989A4 (fr) | Composition pharmaceutique stable | |
ZA201206589B (en) | Incotine containing formulation | |
PT2521445T (pt) | Formulação e utilização da mesma | |
GB201003218D0 (en) | Improvements relating to platform devices | |
HK1153400A1 (en) | Stable ready to use injectable paracetamol formulation | |
IL206739A0 (en) | Injectable pharmaceutical composition | |
GB201311029D0 (en) | Pre-filled sing-use syringe | |
EP2536688A4 (fr) | Formes posologiques stables de levomilnacipran | |
GB201005992D0 (en) | Formulation | |
GB201001978D0 (en) | Formulation | |
PL393180A1 (pl) | Preparat weterynaryjny | |
PL390421A1 (pl) | Preparat weterynaryjny | |
TWM401294U (en) | Hoe with effect of increasing stability |